OSE-CYTOMASK Trademark

Trademark Overview


On Monday, July 24, 2023, a trademark application was filed for OSE-CYTOMASK with the United States Patent and Trademark Office. The USPTO has given the OSE-CYTOMASK trademark a serial number of 98098906. The federal status of this trademark filing is REGISTERED as of Tuesday, October 29, 2024. This trademark is owned by OSE Immunotherapeutics. The OSE-CYTOMASK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of cancer and autoimmune diseases; Sanitary preparations for medical purposes; Dietetic foods and beverages adapted for medical use; Medicines for human purposes, namely, medicines for treating cancer and autoimmune diseases; Chemical preparations for medical or pharmaceutical purposes, namely, treating cancer and autoimmune diseases; Vaccines; medicated serums for the treatment of cancer and autoimmune diseases; Chemical reagents for medical use; Disinfectants; Pharmaceutical preparations for the treatment of autoimmune diseases; Immunostimulants; Immunomodulators; Immunoassay reagents for medical use; Biological preparations for the treatment of cancer; Biological preparations for the treatment of cancer and autoimmune diseases; Monoclonal antibodies for use in disease testing
ose-cytomask

General Information


Serial Number98098906
Word MarkOSE-CYTOMASK
Filing DateMonday, July 24, 2023
Status700 - REGISTERED
Status DateTuesday, October 29, 2024
Registration Number7548048
Registration DateTuesday, October 29, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 13, 2024

Trademark Statements


Goods and ServicesPharmaceuticals for the treatment of cancer and autoimmune diseases; Sanitary preparations for medical purposes; Dietetic foods and beverages adapted for medical use; Medicines for human purposes, namely, medicines for treating cancer and autoimmune diseases; Chemical preparations for medical or pharmaceutical purposes, namely, treating cancer and autoimmune diseases; Vaccines; medicated serums for the treatment of cancer and autoimmune diseases; Chemical reagents for medical use; Disinfectants; Pharmaceutical preparations for the treatment of autoimmune diseases; Immunostimulants; Immunomodulators; Immunoassay reagents for medical use; Biological preparations for the treatment of cancer; Biological preparations for the treatment of cancer and autoimmune diseases; Monoclonal antibodies for use in disease testing

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 22, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOSE Immunotherapeutics
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressNantes 44200
FR

Party NameOSE Immunotherapeutics
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressNantes 44200
FR

Party NameOSE Immunotherapeutics
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressNantes 44200
FR

Trademark Events


Event DateEvent Description
Thursday, July 27, 2023NEW APPLICATION ENTERED
Tuesday, August 22, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, November 26, 2023ASSIGNED TO EXAMINER
Tuesday, November 28, 2023NON-FINAL ACTION WRITTEN
Tuesday, November 28, 2023NON-FINAL ACTION E-MAILED
Tuesday, November 28, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 8, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 8, 2024ASSIGNED TO LIE
Wednesday, July 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 13, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 13, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 29, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 29, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED